Showing results (151-160 of 317) with videos related to

Sort By:
Pageof 32
Cancer Research|September 1, 1994
Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogeneC Castelli, M Sensi, R Lupetti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblastsM P Colombo, G Ferrari, G Biondi, et al.
Journal of Cellular Physiology|March 29, 2000
New dimensions in cancer biology and therapyG G Giordano, L Sigalotti, M Maio
European Journal of Immunology|August 26, 1998
The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I allelesD Pende, L Accame, L Pareti, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1991
Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cellsM Rodolfo, C Salvi, C Bassi, et al.
International Journal of Cancer|April 22, 1993
In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5L Rivoltini, V Viggiano, S Spinazzè, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cellsM P Colombo, L Lombardi, A Stoppacciaro, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1994
Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patientsA Boiardi, A Silvani, P A Ruffini, et al.
The Journal of Experimental Medicine|April 1, 1991
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivoM P Colombo, G Ferrari, A Stoppacciaro, et al.
International Journal of Cancer|March 12, 1991
The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotypeL Rivoltini, G Cattoretti, F Arienti, et al.
Pageof 32